首页 正文

Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic

{{output}}
Glioblastoma, the most common primary malignant brain tumor, is among the most difficult cancers to treat. Despite the aggressive standard of care, including surgical removal followed by radiotherapy with concomitant and adjuvant chemotherapy, the often sudden... ...